Access Labcorp Draw

The CIRS panel measures markers associated with Chronic Inflammatory Response Syndrome (CIRS). It aids in evaluating systemic inflammation and immune dysregulation, facilitating accurate diagnosis and tailored treatment plans for patients with CIRS-related conditions.

This test measures fibrinogen antigen, an essential factor in the blood clotting process. It is useful for diagnosing bleeding disorders, monitoring the presence of inflammatory disease, and evaluating clotting dysfunction.

This test measures antibodies to Hepatitis A. Total anti-HAV testing is used primarily to determine exposure to HAV either naturally or as a result of vaccination.

This test identifies a patient's HLA DRB1/3/4/5 and DQB1 genotypes.

This is a single-marker test measuring adiponectin. Adiponectin has been associated with insulin resistance and linked with type II diabetes, glucose and lipid metabolism, cardiovascular health, and inflammatory processes.

This is a single-marker test measuring sodium.

This test measures IgM antibodies to EBV viral capsid antigen (VCA). It is used to aid in the diagnosis of infectious mononucleosis.

This is a single-marker test measuring the concentration of glial fibrillary acidic protein (GFAP) in serum. GFAP is a biomarker of astroglial cell injury and is utilized in the evaluation of neurological conditions, including traumatic brain injury, neurodegenerative diseases, and certain types of brain tumors. Elevated levels of GFAP can indicate astrocyte damage and assist in clinical decision-making for neurological disorders.

This test quantifies the serum levels of total and free DHT using liquid chromatography-tandem mass spectrometry (LC/MS) and dialysis. It aids in diagnosing and managing conditions related to altered androgen metabolism. It is particularly useful in evaluating conditions such as 5-alpha-reductase deficiency, a genetic disorder that can impact male sexual development.

This test is designed to investigate chronic alcohol abuse. Heavy alcohol use (defined as >4 or 5 beverages per day for two weeks or more) is commonly associated with elevated CDT levels.